Skip to content

Ultrasound study of fetal organs in diabetic pregnancies and its impact on newborn

Sonography of Fetal Abdominal viscera in Pregnancies with Diabetes Mellitus: A Cross ? sectional study in Second and Third trimester and its correlation with perinatal outcome. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/094576
Enrollment
512
Registered
2025-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O244- Gestational diabetes mellitus

Interventions

Intervention1: Nil: Nil

Sponsors

DrTanisha Agrawal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Singleton pregnancies with diabetes who have understood and have given informed consent. - Non- diabetic , uncomplicated pregnancies with same gestational age.

Exclusion criteria

Exclusion criteria: Multi-fetal pregnancy Anomalous fetus

Design outcomes

Primary

MeasureTime frame
To assess fetal abdominal viscera in the second and third trimesters using ultrasound imaging among pregnancies with diabetes and equal number of gestational age- matched non-diabetic healthy pregnanciesTimepoint: 1. Mid trimester during anomaly scan at 18-22 weeks 2. First growth scan between 28+0 to 32+6 weeks 3. Second growth scan between 33+0 to 36+6 weeks 4. Term growth scan between 37+0 to 40 weeks

Secondary

MeasureTime frame
To investigate the correlation between sonographic appearance of fetal abdominal viscera & perinatal outcomes in pregnancies with diabetesTimepoint: 1.At the time of anomaly scan 2.After first growth scan 3.After second growth scan 4.At the time of term growth scan

Countries

India

Contacts

Public ContactDrTanisha Agrawal

Kasturba Medical College, MAHE, Manipal

akhila.vasudeva@manipal.edu9591614792

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026